Sramana Mitra: This is actually a great story. I love stories like this. There’s another entrepreneur whose story I’ve covered. For the first four years, he had no revenue. In the fifth year, they had a million dollars in revenue, and in the sixth year, $100 million. If you’re interested, you can check out his
Sramana Mitra: What were the milestones in your first year of running this? Kerry Cooper: I think there are probably many ways you could look at what the milestones are. We started with six employees. We are 43 today. There is a lot of team growth. We have a great team now. Frankly at 43, it’s
Sramana Mitra: If you have the stomach and the resilience to stick it out, it gives you the ammunition and ability to gather up a lot of competitive advantage. It’s not easy to build up that kind of competitive advantage in a short order. It’s just a matter of time. If you can survive those
Sramana Mitra: Basically, as per the structure of your company that you described, you’re actually going in the right direction. If you want to run a custom solution services company, that’s different. If you’re trying to productise and run more of a product-centric company, you’re going to need to focus. Otherwise, positioning a product becomes
Sramana Mitra: Let’s track the story of how you got this going. What was the beginning of the business? How did you get it started? Did you raise money or did you bootstrap? Give me more color on the entrepreneurial journey. Kerry Copper: Our founder is Jerry Dyess. He built this business out of his
Entrepreneurs are invited to the 291st FREE online 1M/1M roundtable mentoring session on Thursday, January 28, 2016, at 8 a.m. PST/11 a.m. EST/9:30 p.m. India IST. If you are a serious entrepreneur, register to “pitch” and sell your business idea to Sramana Mitra. You’ll gain straightforward feedback, advice on next steps, and she’ll answer any
In case you missed it, you can listen to the recording here:
Sramana Mitra: In that revenue model, what does an average deal size look like? Brian Loew: I’ll answer that but also, the other part of research that has actually become larger than that is the market research side of it where pharmaceutical companies want to know about patient perspectives on things. Typically, a pharma will